Osaic Holdings
RNAC icon

Osaic Holdings’s Cartesian Therapeutics RNAC Stock Holding History

Osaic Holdings’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.85K Buy
302
+195
+182% +$1.39K ﹤0.01% 7066
2025
Q4 		$770 Sell
107
-197
-65% -$1.59K ﹤0.01% 7337
2025
Q3 		$3.09K Hold
304
– – ﹤0.01% 6986
2025
Q2 		$3.16K Buy
304
+200
+192% +$2.13K ﹤0.01% 6775
2025
Q1 		$1.37K Sell
104
-66
-39% -$1.18K ﹤0.01% 6720
2024
Q4 		$3.04K Sell
170
-64
-27% -$1.3K ﹤0.01% 6441
2024
Q3 		$3.77K Sell
234
-62
-21% -$969 ﹤0.01% 6339
2024
Q2 		$6.35K Buy
296
+58
+24% +$1.38K ﹤0.01% 6049
2024
Q1 		$4.64K Sell
238
-64
-21% -$1.36K ﹤0.01% 6119
2023
Q4 		$6.25K Buy
302
+16
+6% +$478 ﹤0.01% 6067
2023
Q3 		$9.1K Buy
286
+25
+10% +$835 ﹤0.01% 5966
2023
Q2 		$8.77K Sell
261
-167
-39% -$5.98K ﹤0.01% 6037
2023
Q1 		$17.8K Buy
428
+33
+8% +$1.55K ﹤0.01% 5633
2022
Q4 		$14.2K Buy
395
+73
+23% +$3.11K ﹤0.01% 5759
2022
Q3 		$16K Sell
322
-1,129
-78% -$62K ﹤0.01% 5756
2022
Q2 		$57K Buy
1,451
+1,334
+1,140% +$39.6K ﹤0.01% 4859
2022
Q1 		$5K Hold
117
– – ﹤0.01% 6498
2021
Q4 		$12K Hold
117
– – ﹤0.01% 6147
2021
Q3 		$14K Hold
117
– – ﹤0.01% 6022
2021
Q2 		$15K Buy
117
+111
+1,850% +$13.2K ﹤0.01% 5832
2021
Q1 		$1K Buy
+6
New +$745 ﹤0.01% 6686
2020
Q3 		– Sell
-3
Closed – – 6378
2020
Q2 		$0 Buy
+3
New +$272 ﹤0.01% 6291

Other funds holding RNAC

Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Osaic Holdings's RNAC Position: Q1 2026 in Review

Osaic Holdings increased its Cartesian Therapeutics (RNAC) stake by 182% in Q1 2026, buying an estimated $1.39K and bringing the position to 302 shares worth $1.85K. The position accounts for ﹤0.01% of the portfolio, ranked #7066.

Osaic Holdings first reported a position in RNAC in Q2 2020 and has held it in 22 quarters since. The position peaked at $57K in Q2 2022. 83 funds tracked by Wall St. Rank hold RNAC as of Q1 2026.

  • Osaic Holdings held 302 shares of Cartesian Therapeutics worth $1.85K as of Q1 2026.
  • Osaic Holdings bought 195 Cartesian Therapeutics shares in Q1 2026, an estimated $1.39K.
  • Cartesian Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7066 holding.
  • Osaic Holdings first reported a position in Cartesian Therapeutics in Q2 2020 and has held it in 22 quarters since.
  • Osaic Holdings's Cartesian Therapeutics position peaked at $57K in Q2 2022.
  • 83 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.